Company news

Sino Medical Sciences Technology Inc. Class A (SSE:688108) news

Sino Medical Sciences Technology Inc. Class A news releases on 6ix. Latest, Sep 15, 2026: "Sino Medical Sciences Technology Inc."Announcement on Voluntary…

Sino Medical Sciences Technology Inc. Class A (SSE:688108) news

Press releases & updates

"Sino Medical Sciences Technology Inc."Announcement on Voluntary Disclosure of Domestic Medical Device Registration Certificates Obtained for Products of a Subsidiary

"Sino Medical Sciences Technology Inc."Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the SSE STAR Market Medical Device and Medical Equipment Industry

"Sino Medical Sciences Technology Inc."Announcement on Voluntary Disclosure of Obtaining a Medical Device Registration Certificate of the People's Republic of China for Subsidiary's Product

"Sino Medical Sciences Technology Inc."Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction

"Sino Medical Sciences Technology Inc."Announcement on Convening the 2026 Semi-annual Performance Briefing

"Sino Medical Sciences Technology Inc."Announcement on Voluntary Disclosure of a Subsidiary's Products Obtaining Registration Approval Overseas

"Sino Medical Sciences Technology Inc."Announcement on the Subsidiary's Self-Expanding Intracranial Drug-Coated Stent System Obtaining EU MDR Certification

"Sino Medical Sciences Technology Inc."Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026

"Sino Medical Sciences Technology Inc."Voluntary Disclosure Announcement on the Overseas Registration Certificate Obtained for the Company's Product

Announcement on Resolutions of the 5th Extraordinary General Meeting in 2026

Announcement on Resolutions of the 14th Special Meeting of Independent Directors of the 3rd Board of Directors

Announcement on Voluntary Disclosure of Obtaining Registration Certificate for the Company's Products Overseas

Announcement on Voluntary Disclosure of Obtaining EU Approval for Shortening Dual Antiplatelet Therapy Duration to One Month for All Patient Populations Using the Company’s Coronary Stent Products

Announcement on Resolutions of the 17th Meeting of the 3rd Board of Directors

Announcement on Implementation Result of Shares Repurchase and Share Changes

Announcement on Convening the Q1 2026 Performance Briefing

Announcement on Resolutions of the 4th Extraordinary General Meeting in 2026

Report for Q1 2026

Notice on Convening the 4th Extraordinary General Meeting in 2026

Announcement on Resolutions of the 3rd Extraordinary General Meeting in 2026

Announcement on Resolutions of the 2025 Annual General Meeting

Announcement on Progress in Repurchasing Shares

Notice on the 3rd Extraordinary General Meeting in 2026

Announcement on Remuneration Plan for Directors, Supervisors and Senior Management Members in 2025

Announcement on Convening the 2025 Annual Performance Briefing

Announcement on Resolutions of the 2nd Extraordinary General Meeting in 2026

Announcement on Shareholding of Top Ten Shareholders and Top Ten Unrestricted Shareholders Before the Record Date of the Shareholders’ Meeting Regarding the Share Repurchase Matter

Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026

Announcement on Resolutions of the 12th Meeting of the 3rd Board of Directors

Announcement on Subsidiary's Product Obtaining EU CE MDR Certification

Announcement on Resolutions of the 11th Meeting of the 3rd Board of Directors

Announcement on the Company’s Coronary Products Obtaining the Domestic Device Registration Certification

Announcement on Expected Increase in Performance for 2025

Announcement on Resolutions of the 10th Meeting of the 3rd Board of Directors

Announcement on the 2nd Vesting Result in the 3rd Vesting Period of the Initial Grant Part of the Company's 2022 Restricted Stock Incentive Plan and the Listing and Circulation of the Shares

Announcement on U.S. Subsidiary eLum's Borrowing from a Related Party and the Related Party Transaction

Announcement on Election of Employee Director

Announcement on the Adjustment of Members of Board of Directors and Determination of Allowances for External Non-independent Directors

Announcement on Voluntary Disclosure of Obtaining Registration Certificate for the Company's Coronary Stent Products Overseas

赛诺医疗科学技术股份有限公司关于公司冠脉球囊产品在海外获得注册证的自愿性披露公告

Announcement on Convening the Q3 2025 Performance Briefing

Announcement on Voluntary Disclosure of the Company’s Non-Slip Element (NSE) Balloon Product Obtaining Foreign Device Registration Certification

Announcement on Resolutions of the 7th Meeting of the 3rd Board of Supervisors

Announcement on Voluntary Disclosure of the Non-Approval of a Subsidiary's Product Registration Application by the National Medical Products Administration

Indicative Announcement on Changes in Shareholder's Equity

Indicative Announcement on Result of Shareholders' Shareholding Reduction and Change in Equity Interests

Announcement on Attending the Semi-annual Collective Performance Briefing for Medical Device and Equipment Companies on SSE STAR Market 2025

Announcement on Receiving Decision on Administrative Supervision Measures from Tianjin Securities Regulatory Bureau

Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-Annual Report Performance Briefing

Announcement on Shareholding Reduction Plan for Shareholders with Over 5% Shares